misonneh's profile

Recent Activity

• 06:10: posted Common disorders are quantitative traits
• 06:05: added a note to Epigenetics: An expanding horizon for DNA methylation
• 06:04: posted Epigenetics: An expanding horizon for DNA methylation
• 05:56: posted Polycomb group proteins: navigators of lineage pathways led astray in cancer
• 05:48: posted ABCB1 Pharmacogenetics: Progress, Pitfalls, and Promise
• 05:41: posted Paving the Critical Path: How can Clinical Pharmacology Help Achieve the Vision?
• 05:39: posted The Prospects for |[ldquo]|Personalized Medicine|[rdquo]| in Drug Development and Drug Therapy
• 05:36: posted Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation
• 05:28: posted Cytochrome P4502D6 (CYP2D6) Gene Locus Heterogeneity: Characterization of Gene Duplication Events
• 05:26: posted Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms
• 02:18: posted Genomics: We are individuals
• 02:07: added a note to Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.
• 02:06: posted Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.
• 01:57: added a note to MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.
• 01:55: posted MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

• 03:27: posted Genetic Influences on the Pharmacokinetics of Orally and Intravenously Administered Digoxin as Exhibited by Monozygotic Twins
• 03:16: posted Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis
• 02:40: posted Current Understanding of the Pharmacogenomics of Metformin

• 02:00: added a note to Genebanks: A Comparison of Eight Proposed International Genetic Databases
• 01:22: joined the group Biobank Database

• 03:26: invitation from Mi-Seon to join the group Biobank Database

• 16:36: posted Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer.
• 16:20: posted Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes can alter risk rapidly.
• 16:08: posted Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence.
• 16:07: posted Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary.
• 12:35: posted Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.

• 08:28: posted The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
• 08:28: posted The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
• 08:27: posted PharmGED: pharmacogenetic effect database.
• 08:25: posted The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.
• 08:15: posted HGVbaseG2P: a central genetic association database.
• 08:13: posted The SNP Consortium website: past, present and future.
• 08:10: posted The International HapMap Project Web site.
• 08:06: posted Data integration and genomic medicine.
• 08:03: posted The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine.
• 07:59: posted UK Biobank: from concept to reality.
• 06:24: posted Feature selection and nearest centroid classification for protein mass spectrometry.
• 06:23: posted Biomarker identification by feature wrappers.
• 05:57: posted Basal-like breast cancer: a critical review.
• 05:55: posted The Nottingham prognostic index for invasive carcinoma of the breast.
• 05:49: posted MicroRNA involvement in the pathogenesis and management of breast cancer
• 05:48: posted Triple-negative/basal-like breast cancer: review.
• 05:44: posted Basal-like and Triple-Negative Breast Cancer: Definition and Therapeutic Insights - ASCO
• 05:42: posted Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
• 05:17: posted The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2--response to therapy, other indications, and future directions.
• 05:16: posted The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1--Overview, Detection, and Staging